Literature DB >> 16096374

Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4.

Abdullah Ozer1, Richard K Bruick.   

Abstract

Many cellular responses to changes in O2 availability are mediated through the hypoxia inducible transcription factor, HIF. HIF regulation is largely dependent on the activity of O2-dependent prolyl hydroxylases. Under normoxic conditions, these enzymes modify HIF to promote its proteasomal degradation. Recently we proposed a second function for the HIF prolyl hydroxylases--recruitment of the candidate tumor suppressor protein ING4 to HIF under hypoxic conditions. Rather than affecting hydroxylase activity or HIF stability, ING4 mediates the ability of HIF to activate transcription of its downstream target genes. This additional mechanism of HIF regulation may serve to fine-tune the magnitude of the cellular hypoxic response under physiological conditions. Furthermore, the identification of a link between ING4 and HIF may shed light on a mechanism by which misregulation of ING4 in tumors promotes angiogenesis, loss of contact inhibition, and changes in cellular proliferation and survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16096374     DOI: 10.4161/cc.4.9.2040

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  16 in total

1.  ING4 is negatively correlated with microvessel density in colon cancer.

Authors:  Chun Lou; Shixiong Jiang; Xinggang Guo; Xin-shu Dong
Journal:  Tumour Biol       Date:  2012-09-28

2.  Downregulated expression of inhibitor of growth 4 (ING4) in advanced colorectal cancers: a non-randomized experimental study.

Authors:  Qi You; Xi-Shan Wang; Song-Bin Fu; Xiao-Ming Jin
Journal:  Pathol Oncol Res       Date:  2011-05-31       Impact factor: 3.201

Review 3.  Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity.

Authors:  Vivek Bhakta Mathema; Young-Sang Koh
Journal:  Tumour Biol       Date:  2011-10-05

Review 4.  Inhibitor of growth tumor suppressors in cancer progression.

Authors:  Brad Piche; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-03-02       Impact factor: 9.261

5.  Expression of tumor suppressor gene ING4 in ovarian carcinoma is correlated with microvessel density.

Authors:  Yinglan Liu; Liqian Yu; Yingwei Wang; Yaling Zhang; Yingchao Wang; Guangmei Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-08       Impact factor: 4.553

6.  ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation.

Authors:  Tiffany Hung; Olivier Binda; Karen S Champagne; Alex J Kuo; Kyle Johnson; Howard Y Chang; Matthew D Simon; Tatiana G Kutateladze; Or Gozani
Journal:  Mol Cell       Date:  2009-01-30       Impact factor: 17.970

Review 7.  INGs are potential drug targets for cancer.

Authors:  Runyun Zhang; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

Review 8.  Inhibitor of growth-4 is a potential target for cancer therapy.

Authors:  Shuping Yuan; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  Tumour Biol       Date:  2016-01-23

Review 9.  Reviewing the current classification of inhibitor of growth family proteins.

Authors:  Motoko Unoki; Kensuke Kumamoto; Seiichi Takenoshita; Curtis C Harris
Journal:  Cancer Sci       Date:  2009-04-28       Impact factor: 6.716

10.  The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes.

Authors:  Susan Nozell; Travis Laver; Dorothy Moseley; Lisa Nowoslawski; Marijke De Vos; George P Atkinson; Keith Harrison; L Burton Nabors; Etty N Benveniste
Journal:  Mol Cell Biol       Date:  2008-09-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.